NCT00125645View on ClinicalTrials.gov

Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 1, 2005

Primary Completion Date

September 1, 2011

Study Completion Date

September 1, 2011

Conditions
Myocardial Infarction
Interventions
DRUG

Irbesartan Oral Tablet

Trial Locations (1)

6700

Kardiologisk Klinik, Centralsygehuset Esbjerg/Varde, Esbjerg

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

University of Southern Denmark

OTHER

NCT00125645 - Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study) | Biotech Hunter | Biotech Hunter